Shaheen Pandie.

Indicus pranii with placebo, 75.9 percent of the patients in the M. Indicus pranii group and 81.4 percent of these in the placebo group honored the regimen for the full 3 months of the study treatment. Of the 1400 sufferers signed up for the trial, 76.6 percent were receiving antituberculosis treatment during randomization, and 14.5 percent were receiving antiretroviral treatment . The rates of ongoing usage of antituberculosis therapy and antiretroviral therapy through the trial are shown in Tables S12 and S13 in the Supplementary Appendix.